AI Features Are Becoming a Commodity, and Cloud Prices Show ItDiego LopezOctober 18, 20260 Analysis: a free model beating AWS and Google at image moderation shows AI features commoditising — and cloud pricing models built on scarcity giving way.
NeoVax Analysis: Feasibility Proven, Efficacy Still UnprovenDiego LopezOctober 16, 20260 NeoVax cleared its first gate: feasible, acceptably safe, immunologically active. Why that is progress, and why it is not proof it works.
